| Literature DB >> 20077153 |
Elizabeth M Yano1, Patricia Hayes, Steven Wright, Paula P Schnurr, Linda Lipson, Bevanne Bean-Mayberry, Donna L Washington.
Abstract
The Department of Veterans Affairs (VA) and other federal agencies require funded researchers to include women in their studies. Historically, many researchers have indicated they will include women in proportion to their VA representation or pointed to their numerical minority as justification for exclusion. However, women's participation in the military-currently 14% of active military-is rapidly changing veteran demographics, with women among the fastest growing segments of new VA users. These changes will require researchers to meet the challenge of finding ways to adequately represent women veterans for meaningful analysis. We describe women veterans' health and health-care use, note how VA care is organized to meet their needs, report gender differences in quality, highlight national plans for women veterans' quality improvement, and discuss VA women's health research. We then discuss challenges and potential solutions for increasing representation of women veterans in VA research, including steps for implementation research.Entities:
Mesh:
Year: 2010 PMID: 20077153 PMCID: PMC2806960 DOI: 10.1007/s11606-009-1116-4
Source DB: PubMed Journal: J Gen Intern Med ISSN: 0884-8734 Impact factor: 5.128
Women Veterans Health Strategic Health-Care Group Priorities: Building a Quality Improvement Research Agenda for Women
| Strategic priorities | Quality Improvement research opportunities |
|---|---|
| Redesign primary care delivery for women veterans to integrate gender-specific services | • Evaluate variations in care |
| • Evaluate quality of care delivered under different care models | |
| • Develop and test new care models | |
| • Develop and test provider education interventions to advance their interest and proficiency in women’s health | |
| • Develop and evaluate computerized decision support interventions to support integration of gender-specific care in routine primary care visits | |
| • Develop and evaluate patient navigation and/or care management interventions to support coordination across VA providers, between VA/contract providers | |
| Accurately represent and evaluate women veterans’ health and health-care needs through data and analysis | • Evaluate determinants of gender disparities in quality (e.g., patient, provider, organizational, area) |
| • Identify predictors of quality in high vs. low performing VA networks and/or facilities (outliers) | |
| • Collect new primary data needed to characterize health or health care needs not already captured by administrative or performance data (e.g., gender-sensitive patient satisfaction) | |
| • Develop and evaluate new gender-specific performance measures (e.g., follow-up of abnormal Pap smears) | |
| • Adapt and evaluate “best practice” interventions and other innovations from private or other public sectors for use in VA | |
| • Adapt interventions found to be effective among male veterans for use among women veterans (e.g., in different clinic venues, with adapted study materials, on related conditions) | |
| Post-deployment health and readjustment issues among women veterans | • Assess health and health care needs among returning women veterans |
| • Evaluate determinants of post-deployment high utilization among women veterans | |
| • Evaluate patterns of injury and illness, including possible exposures to toxic substances, animal exposures, evaluation for depleted uranium exposure from munitions and shielding | |
| • Evaluate quality of care for menstrual disorders, contraceptive management (consequences of continuous use), pregnancy, infertility, urinary tract infections (anecdotal reports of high rates) | |
| • Evaluate quality of care coordination for comorbid physical and mental health conditions | |
| • Evaluate transitions from active duty/guard/reserve to home (including role impacts for mothers, such as attachment disruption and parenting issues, and as civilian employees) | |
| • Develop and test quality improvement interventions based on identified quality gaps | |
| Implement risk reduction strategies in prescribing medications | • Evaluate patterns of medication use among women veterans (including access/use of medications with teratogenic properties as well as informed consent) |
| • Evaluate access to contraception when appropriate | |
| • Develop and test interventions for reducing risk of medication prescribing (errors, dosage problems, contraindications, adverse events) |
Current VA Women’s Health Services Research Portfolio (Through FY08)*
| General topic | Funded research studies |
|---|---|
| Health-care needs, utilization, outcomes, and quality | • Chronic physical and mental illness care in women veterans |
| • Assessment of preventive and chronic disease measures in women veterans | |
| • Women veterans’ ambulatory care use project | |
| • Improving VA access and quality of care for women | |
| • Alcohol misuse and the risk of post-surgical complication and mortality | |
| • The quality of locoregional breast cancer treatment for breast cancer in VA | |
| • Study of women veterans in menopause | |
| Organization of health services to women veterans | • Impact of practice structure on quality of care for women veterans |
| • Implementation and sustainability of VA women’s mental health clinics | |
| Sexual trauma, military sexual trauma (MST), intimate partner violence | • Sexual violence and women veterans gynecological health |
| • Physical and sexual assault in deployed women: risks, outcomes and services | |
| • Evaluation of military sexual trauma screening and treatment | |
| • Longitudinal study of MST effects on PTSD and health behavior among women Marines | |
| • Detection of intimate partner violence: Implications for intervention | |
| • Combat, sexual assault, and PTSD in OEF/OIF military women | |
| Posttraumatic stress disorder (PTSD) | • Gender and medical needs of OEF/OIF veterans with PTSD and comorbid substance abuse |
| • Examining the diagnostic and clinical utility of the PTSD checklist | |
| • Barriers and facilitators to PTSD treatment seeking | |
| • Re-engineering systems for the primary care treatment of PTSD | |
| • Pilot study of PTSD-focused cognitive behavioral therapy for partner violence | |
| Post-deployment health and other related research | • Women veterans cohort study |
| • Further development and validation of the DRRI | |
| • Predicting post-deployment mental health, substance abuse, and service needs | |
| • Community re-integration and service needs for women veteran mothers |
*This portfolio represents studies funded by VA HSR&D Service. Other VA Office of Research & Development Services and the Department of Defense also fund research relevant to women veterans that are not captured by this portfolio review. 38–39
OEF/OIF refers to Operation Enduring Freedom and Operation Iraqi Freedom